News tagged ‘ColonCancer’ clear
- The reduced risk of colorectal cancer associated with taking aspirin or
NSAIDs may be confined to individuals already at risk because of
elevations in a particular inflammatory factor in the blood, researchers
at Dana-Farber Cancer Institute and Massachusetts General Hospital
Tags: ColonCancer, Prevention
- Researchers found patients who engaged in moderate physical activity were 53 percent more likely to be free of colorectal cancer than those who were less physically active.
- An observational study is among the first to show that aspirin can
improve survival in colorectal cancer patients who started taking
aspirin following diagnosis.
- The vast majority of advanced colon cancer patients in a clinical trial
were not concerned about the cost of prescription drugs, according to a
study led by Dana-Farber researchers.
Tags: chemotherapy, ColonCancer
- A combination of chemotherapies for colon cancer decreases recurrence
for patients under 70, but not for those who are older, according to
Mayo Clinic and Dana-Farber scientists.
Tags: chemotherapy, BasicResearch, ColonCancer
- Research explores why people with surgically removed colorectal cancer
who are overweight, physically inactive, and follow a Western-pattern
diet may have increased risk of dying from the disease or other causes.
- Dana-Farber scientists show a previously unsuspected gene can
also influence transcription factors and potentially disable tumor
Tags: ColonCancer, Genetics
- Patients diagnosed with colon cancer who had abundant vitamin D
in their blood were less likely to die during a follow-up period than
those who were deficient in the vitamin, according to a new study by
scientists at Dana-Farber Cancer Institute.
- Researchers at Dana-Farber have uncovered a cancer paradox: A
family history of colon or rectal cancer doubles one's risk of the
disease — but improves the odds of survival should the cancer develop.
Showing 11-20 of 23 items